Ion Baciu
University of Bucharest
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ion Baciu.
Molecules | 2009
Dana Stan; Iulia Matei; Carmen Mihailescu; Mihaela Savin; Mihaela Matache; Mihaela Hillebrand; Ion Baciu
Binding of a newly synthesized indanedione derivative, 2-(2-hydroxy-3-ethoxybenzylidene)-1,3-indanedione (HEBID), to human and bovine serum albumins (HSA and BSA), under simulated physiological conditions was monitored by fluorescence spectroscopy. The binding parameters (binding constants and number of binding sites) and quenching constants were determined according to literature models. The quenching mechanism was assigned to a Förster non-radiative energy transfer due to the HEBID-SA complex formation. A slightly increased affinity of HEBID for HSA was found, while the number of binding sites is approximately one for both albumins. The molecular distance between donor (albumin) and acceptor (HEBID) and the energy transfer efficiency were estimated, in the view of Förster’s theory. The effect of HEBID on the protein conformation was investigated using circular dichroism and synchronous fluorescence spectroscopies. The results revealed partial unfolding in the albumins upon interaction, as well as changes in the local polarity around the tryptophan residues.
Bioorganic & Medicinal Chemistry | 2015
Lilia Matei; Coralia Bleotu; Ion Baciu; Carmen C. Diaconu; Otilia Banu; Petre Ionita; Anca Paun; Arnaud Tatibouët; Irina Zarafu
A series of several new isoniazid derivatives, isonicotinic acid 2-(2-hydroxy-8-substituted-tricyclo[7.3.1.0(2.7)]tridec-13-ylidene)-hydrazides, were synthesized and fully characterized. These new isoniazid derivatives were studied regarding their antibacterial activity and cytotoxicity, as well as their influences on some metabolizing enzymes. The best anti-mycobacterial activity was observed in the case of compounds containing alkyl side chains in the 8 position of tricyclo[7.3.1.0(2.7)]tridec-13-ylidene group. On contrary, the antimicrobial activity of these new compounds against various non-tuberculosis strains showed the best activity to be with the phenyl side chain of compound 6. It proved also to be the most toxic, inducing apoptosis and blocking the cell cycle in G0/G1 phase. The cell cycle was blocked in G0/G1 phase also by compound 3, but this compound did not show any toxicity. All compounds induced the expression of NAT1 and NAT2 genes in HT-29 cell line, and the expression of CYP1A1 in HT-29 and HCT-8 cell lines. The expression level of CYP3A4 was increased by compounds 1, 6 and 7 in HCT-8 cells. These results indicated that the activation of other metabolizing pathways, apart from those of isoniazid, take place. It might also point out the possibility of an increased isoniazid acetylation ratio by co-administration with new compounds in slow acetylators.
Journal of Biological Inorganic Chemistry | 2012
Ioana Dumitru; Cristian D. Ene; Augustin M. Ofiteru; Codruta C. Paraschivescu; Augustin M. Madalan; Ion Baciu; Ileana C. Farcasanu
Superoxide dismutases (SODs) stand in the prime line of enzymatic antioxidant defense in nearly all eukaryotic cells exposed to oxygen, catalyzing the breakdown of the superoxide anionic radical to O2 and H2O2. Overproduction of superoxide correlates with numerous pathophysiological conditions, and although the native enzyme can be used as a therapeutic agent in superoxide-associated conditions, synthetic low molecular weight mimetics are preferred in terms of cost, administration mode, and bioavailability. In this study we make use of the model eukaryote Saccharomyces cerevisiae to investigate the SOD-mimetic action of a mononuclear mixed-ligand copper(II) complex, [CuCl(acac)(tmed)] (where acac is acetylacetonate anion and tmed is N,N,N′,N′-tetramethylethylenediamine). Taking advantage of an easily reproducible phenotype of yeast cells which lack Cu–Zn SOD (Sod1p), we found that the compound could act either as a superoxide scavenger in the absence of native Sod1p or as a Sod1p modulator which behaved differently under various genetic backgrounds.
Jpc-journal of Planar Chromatography-modern Tlc | 2003
Adrian Beteringhe; Ion Baciu; Miron T. Caproiu; Titus Constantinescu; Alexandru T. Balaban
The Z (1b and 2b, respectively) and E diastereomers (1c and 2c, respectively) of the O-methyloximes of testosterone (1a) and 17a-methyltestosterone (2a) have been synthesized and separated by TLC. 1H NMR assignments confirmed the corresponding structures. The TLC RF values of these six compounds could be rationalized by a quantitative structure-property relationship (QSPR) using one topological/topographical index.
international semiconductor conference | 2011
Carmen-Marinela Mihailescu; Ion Baciu; Dana Stan; Carmen Moldovan; Rodica Iosub; Adi Dinescu; Munizer Purica; Mihaela Savin
The purpose of the present work is to test of a new biosurface for qualitative detection of E. coli O157:H7 by SEM and Ellipsometry methods. The bacteria are attached onto surface with a method based on reactions between antibodies and antigens, very specific to bacterial serotypes that cause food safety concerns: E.coli O157:H7.
international semiconductor conference | 2009
Monica Simion; Irina Kleps; Lavinia L. Ruta; Lucia Lazar; Adina Bragaru; Mihaela Miu; Ion Baciu
This paper reviews some of the most important technical aspects related to the reader system used in microarray technology straightening the importance of the working conditions for the accuracy of the data as well as the measures which should be considered for optimization of the detection process with exemplification on porous substrate printed with bovine serum albumin (BSA) labelled with Cy3 fluorophore.
Tetrahedron Letters | 2009
Cristian Dobrotă; Codruţa C. Paraschivescu; Ioana Dumitru; Mihaela Matache; Ion Baciu; Lavinia L. Ruţă
Tetrahedron | 2009
Mihaela Matache; Cristian Dobrota; Niculina D. Bogdan; Ioana Dumitru; Lavinia L. Ruta; Codruta C. Paraschivescu; Ileana C. Farcasanu; Ion Baciu; Daniel P. Funeriu
Thin Solid Films | 2012
Dana Stan; Carmen-Marinela Mihailescu; Rodica Iosub; Carmen Moldovan; Mihaela Savin; Ion Baciu
Bioorganic & Medicinal Chemistry | 2013
Lilia Matei; Coralia Bleotu; Ion Baciu; Constantin Draghici; Petre Ionita; Anca Paun; Mariana Carmen Chifiriuc; Adriana Sbarcea; Irina Zarafu